# FSD Pharma Inc. (HUGE)

Source: https://www.quantisnow.com/company/HUGE
Generated: 2026-11-12T05:46:47.308Z

- Ticker: HUGE
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: fsdpharma.com

## About

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, Canada.

## Latest HUGE news and filings

- 2025-05-30 11:00 UTC [Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari](https://www.quantisnow.com/insight/quantum-biopharma-receives-235-million-usd-from-a-mutually-agreed-global-6064241)
- 2025-04-14 11:30 UTC [Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario](https://www.quantisnow.com/insight/quantum-biopharma-wins-reconsideration-motion-by-dr-raza-bokhari-at-5986171)
- 2025-01-17 12:30 UTC [Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates](https://www.quantisnow.com/insight/quantum-biopharma-in-court-with-dr-raza-bokhari-on-january-5849227)
- 2024-11-25 12:00 UTC [Leadership Update] [Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price Manipulation](https://www.quantisnow.com/insight/quantum-biopharma-previously-known-as-fsd-pharma-nasdaqhuge-csehuge-invites-5789411)
- 2024-08-23 23:30 UTC [Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update](https://www.quantisnow.com/insight/quantum-biopharma-announces-intention-to-complete-debt-settlements-and-provides-5671091)
- 2024-08-15 11:07 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5660557)
- 2024-08-14 10:15 UTC [SEC Form 6-K] [Amendment: SEC Form 6-K/A filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/amendment-sec-form-6-ka-filed-by-fsd-pharma-inc-5658007)
- 2024-08-14 10:13 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5658004)
- 2024-08-12 10:03 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5653776)
- 2024-08-09 11:30 UTC [FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team](https://www.quantisnow.com/insight/fsd-pharma-provides-update-on-its-investment-in-celly-nutrition-5652074)
- 2024-08-09 11:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5652073)
- 2024-07-30 01:04 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5632117)
- 2024-07-09 17:52 UTC [Market Chatter] ['GOP Congressional Committee Approves Bill To Block Marijuana Rescheduling, While Rejecting State Cannabis Protections Amendment' - Marijuana Moment](https://www.quantisnow.com/insight/gop-congressional-committee-approves-bill-to-block-marijuana-rescheduling-while-5599597)
- 2024-07-08 21:16 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5597932)
- 2024-07-08 19:20 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5597228)
- 2024-06-28 21:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5584386)
- 2024-06-28 21:00 UTC [FSD Pharma provides Corporate Update](https://www.quantisnow.com/insight/fsd-pharma-provides-corporate-update-5584363)
- 2024-06-28 11:49 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5582593)
- 2024-06-28 11:33 UTC [Market Chatter] [FSD Pharma Wins Court Judgment Against Former CEO, Dr. Raza Bokhari](https://www.quantisnow.com/insight/fsd-pharma-wins-court-judgment-against-former-ceo-dr-raza-5582534)
- 2024-06-28 11:30 UTC [FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.](https://www.quantisnow.com/insight/fsd-pharma-inc-wins-final-judgment-to-confirm-arbitration-award-5582524)
- 2024-06-27 11:34 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5580042)
- 2024-06-27 11:30 UTC [FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia](https://www.quantisnow.com/insight/fsd-pharma-receives-ethics-committee-approval-for-a-phase-1-multiple-5580021)
- 2024-06-13 11:35 UTC [Market Chatter] [FSD Pharma shares are trading higher after the company entered into an exclusive option agreement with the University of Southern California to evaluate dietary supplement technology for commercialization.](https://www.quantisnow.com/insight/fsd-pharma-shares-are-trading-higher-after-the-company-entered-5555105)
- 2024-06-13 11:31 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5555101)
- 2024-06-13 11:30 UTC [FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications](https://www.quantisnow.com/insight/fsd-pharma-enters-into-an-exclusive-option-agreement-with-the-5555099)
- 2024-06-04 12:28 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5534598)
- 2024-06-04 11:30 UTC [FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication](https://www.quantisnow.com/insight/fsd-pharma-receives-institutional-review-board-approval-to-study-the-5534340)
- 2024-05-31 11:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5527881)
- 2024-05-31 11:30 UTC [FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest](https://www.quantisnow.com/insight/fsd-pharma-inc-wins-petition-to-confirm-arbitration-awards-entered-5527877)
- 2024-05-28 12:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5518810)
- 2024-05-28 12:08 UTC [Market Chatter] [FSD Pharma Submits Clinical Trial Protocol To Assess Safety And Efficacy Of Unbuzzd](https://www.quantisnow.com/insight/fsd-pharma-submits-clinical-trial-protocol-to-assess-safety-and-5518774)
- 2024-05-28 12:00 UTC [FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication](https://www.quantisnow.com/insight/fsd-pharma-submits-a-clinical-trial-protocol-to-study-the-5518732)
- 2024-05-24 18:34 UTC [FSD Pharma Provides Corporate Update](https://www.quantisnow.com/insight/fsd-pharma-provides-corporate-update-5517530)
- 2024-05-24 20:51 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5517325)
- 2024-05-16 17:12 UTC [Market Chatter] [Shares of cannabis stocks are trading higher after Biden said the Justice Department is taking the next steps to reclassify marijuana from Schedule I to Schedule III.](https://www.quantisnow.com/insight/shares-of-cannabis-stocks-are-trading-higher-after-biden-said-5496612)
- 2024-05-16 17:06 UTC [Market Chatter] [President Biden Posts On X "Too Many Lives Have Been Upended Because Of Our Failed Approach To Marijuana. So Today, The @TheJusticeDept Is Taking The Next Step To Reclassify Marijuana From A Schedule I To A Schedule Iii Drug Under Federal Law."](https://www.quantisnow.com/insight/president-biden-posts-on-x-too-many-lives-have-been-5496601)
- 2024-05-16 16:43 UTC [Market Chatter] ['Justice Department Poised To Post Plans For Marijuana Reclassification; This Is The Next Step In The Rescheduling Process Begun By President Joe Biden In October 2022 That Is Set To Be The Largest Shift In Federal Drug Policy In Decades' - Politico](https://www.quantisnow.com/insight/justice-department-poised-to-post-plans-for-marijuana-reclassification-this-5496542)
- 2024-05-16 12:00 UTC [FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)](https://www.quantisnow.com/insight/fsd-pharma-provides-update-on-celly-nus-new-packaging-for-5496025)
- 2024-05-16 12:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5495613)
- 2024-05-15 10:02 UTC [SEC Form 6-K] [SEC Form 6-K filed by FSD Pharma Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-fsd-pharma-inc-5490972)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/HUGE
- Earnings history: https://www.quantisnow.com/earnings/HUGE
- Dividend history: https://www.quantisnow.com/dividends/HUGE
- Insider transactions: https://www.quantisnow.com/insiders/HUGE
- Options chain: https://www.quantisnow.com/options/HUGE
- SEC 8-K filings only: https://www.quantisnow.com/company/HUGE/8-k
- RSS and alerts for HUGE: https://www.quantisnow.com/docs/rss-feeds.md